2-propanol has been researched along with Stroke in 4 studies
2-Propanol: An isomer of 1-PROPANOL. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.
propan-2-ol : A secondary alcohol that is propane in which one of the hydrogens attached to the central carbon is substituted by a hydroxy group.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In investigating potent sodium (Na(+)) channel blockers for the treatment of ischemic stroke, we synthesized a novel series of 3-amino-1-(5-indanyloxy)-2-propanol derivatives and evaluated their inhibitory effects on neuronal Na(+) channels." | 7.78 | Synthesis and pharmacological evaluation of 3-amino-1-(5-indanyloxy)-2-propanol derivatives as potent sodium channel blockers for the treatment of stroke. ( Aoyama, Y; Nonaka, H; Seki, M; Shimada, H; Soejima, A; Tsuruta, O, 2012) |
| "In investigating potent sodium (Na(+)) channel blockers for the treatment of ischemic stroke, we synthesized a novel series of 3-amino-1-(5-indanyloxy)-2-propanol derivatives and evaluated their inhibitory effects on neuronal Na(+) channels." | 3.78 | Synthesis and pharmacological evaluation of 3-amino-1-(5-indanyloxy)-2-propanol derivatives as potent sodium channel blockers for the treatment of stroke. ( Aoyama, Y; Nonaka, H; Seki, M; Shimada, H; Soejima, A; Tsuruta, O, 2012) |
| "Results showed that recurrence of RVO in the same or fellow eye was decreased by more than half in the follow-up group (3." | 1.31 | Nine year follow-up study of morbidity and mortality in retinal vein occlusion. ( Dodson, PM; Kirwan, J; Kritzinger, EE; O'Leary, MB; Prior, P; Tsaloumas, MD; Vinall, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pullagurla, SR | 1 |
| Witek, MA | 1 |
| Jackson, JM | 1 |
| Lindell, MA | 1 |
| Hupert, ML | 1 |
| Nesterova, IV | 1 |
| Baird, AE | 1 |
| Soper, SA | 1 |
| Seki, M | 1 |
| Tsuruta, O | 1 |
| Aoyama, Y | 1 |
| Soejima, A | 1 |
| Shimada, H | 1 |
| Nonaka, H | 1 |
| Ge, J | 1 |
| Guo, L | 1 |
| Wang, S | 1 |
| Zhang, Y | 1 |
| Cai, T | 1 |
| Zhao, RC | 1 |
| Wu, Y | 1 |
| Tsaloumas, MD | 1 |
| Kirwan, J | 1 |
| Vinall, H | 1 |
| O'Leary, MB | 1 |
| Prior, P | 1 |
| Kritzinger, EE | 1 |
| Dodson, PM | 1 |
4 other studies available for 2-propanol and Stroke
| Article | Year |
|---|---|
Parallel affinity-based isolation of leukocyte subsets using microfluidics: application for stroke diagnosis.
Topics: 2-Propanol; Alkenes; Antigens, CD; CD4-Positive T-Lymphocytes; Cell Adhesion Molecules; Cell Separat | 2014 |
Synthesis and pharmacological evaluation of 3-amino-1-(5-indanyloxy)-2-propanol derivatives as potent sodium channel blockers for the treatment of stroke.
Topics: 2-Propanol; Animals; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Microsomes, L | 2012 |
The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke.
Topics: Animals; Cell Separation; Cell Size; Cerebral Cortex; Humans; Injections, Intra-Arterial; Iris; Mese | 2014 |
Nine year follow-up study of morbidity and mortality in retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Comorbidity; Diabetes Melli | 2000 |